Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
P-estro BL is a natural extract-based nutraceutical developed by HL Science, a South Korean company specializing in health functional foods. It is a powder-form oral supplement derived from pomegranate concentrate, specifically formulated to alleviate menopausal symptoms. The product is standardized to contain phytoestrogenic compounds, such as ellagic acid, which are thought to modulate estrogenic activity in the body. While HL Science's liquid concentrate (P-estro HL) is explicitly noted for targeting estrogen receptor beta (ERβ), P-estro BL serves as the powder-based alternative within the same therapeutic category. It is recognized as a functional ingredient for women's health by regulatory authorities in South Korea and is used to manage symptoms like hot flashes and night sweats associated with the menopausal transition.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on P-estro BL.